[1] Bozorgi M, Amin Gh, Shekarchi M, Rahimi R. Medicinal plants of the genus Drimia: a review on traditional uses, phytochemistry, pharmacology and toxicology. J Tradit Chin Med. 2016. In press.
[2] Royal Botanic Gardens, Kew, Missouri Botanical Garden. The Plant List. Version 1.1; Available from: http://www.theplantlist.org/
[3] Ghahreman A. Flora of Iran. Tehran: Research Institute of Forests and Rangelands, 1997.
[4] Pohl TS, Crouch NR, Mulholland DA. Southern african hyacinthaceae: chemistry, bioactivity and ethnobotany. Curr Org Chem. 2000; 4(12): 1287-1324.
[5] Khare CP. Indian medicinal plants. Berlin: Springer, 2007.
[6] Aliotta G, De-Santo NG, Pollio A, Sepe J, Touwaide A. The diuretic use of scilla from dioscorides to the end of the 18th century. J Nephrol. 2004; 17(2): 342-347.
[7] Avicenna. The canon. Translated by Sharafkandi A. Tehran: Soroush Press, 2008.
[8] Jorjani SE. Zakhire Kharazmshahi. Tehran: Tehran University of Medical Sciences, 2013.
[9] Gentry HS, Verbiscar AJ, Banigan TF. Red squill. Econ Bot. 1987; 41(2): 267-282.
[10] Stoll A, Suter E, Kreis W, Bussemaker BB, Hofmann A. Die herzaktivenSubstanzen der Meerzwiebel Scillaren A. Helv Chim Acta. 1933; 16(1): 703-733.
[11] Gould L, Fisch S, Cherbakoff A, Degraff AC. Clinical studies on proscillaridin A, a new squill glycoside. J clin pharmacol new drugs. 1971; 11(2): 135-145.
[12] El-Seedi HR, Burman R, Mansour A, Turki Z, Boulos L, Gullbo J,
Göransson U. The traditional medical uses and cytotoxic activities of sixty-one Egyptian plants: Discovery of an active cardiac glycoside from
Urginea maritima.
J Ethnopharmacol. 2013; 145(3): 746-757.
[13] Bielawski K, Winnicka K, Bielawska A. Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A. Biol Pharm Bull. 2006; 29(7): 1493-1497.
[14] Winnicka K, Bielawski K, Bielawska A, Miltyc W. Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells. Arch Pharm Res. 2007; 30(10): 1216-1224.
[15] Winnicka K, Bielawski K, Bielawska A, Miltyc W. Dual effects of ouabain, digoxin and proscillaridin A on the regulation of apoptosis in human fibroblasts. Nat Prod Res. 2010; 24(3): 274-285.
[16] Feng R, Rios JA, Onishi T, Lokshin A, Gorelik E, Lentzsch S. Cell-based and cytokine-directed chemical screen to identify potential anti-multiple myeloma agents. Leukemia Res. 2010; 34(7): 917-924.
[17] Nilubol N, Zhang L, Shen M, Zhang YQ, He M, Austin CP,
Kebebew E. Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening.
J Transl Med. 2012; 10: 1-15.
[18] Bayazit V, Konar V. Analgesic effects of scilliroside, proscillaridin-A and taxifolin from squill bulb (Urginea maritima) on pains. Dig J Nanomater Bios. 2010; 5(2): 457-465.
[19] Terness P, Navolan D, Dufter C, Kopp B, Opelz G. The T-cell suppressive effect of bufadienolides: structural requirements for their immunoregulatory activity. Int Immuno Pharmacol. 2001; 1(1): 119-134.
[20] Pascual-Villalobos MJ. Anti-insect activity of bufadienolides from urginea maritima. In: Janick J, Whipkey A. Trends in new crops and new uses. Alexandria: Ashs Press, 2002.
[21] Krenn L, Kopp B. Bufadienolides from animal and plant sources. Phytochemistry. 1998; 48(1): 1-29.
[22] Tittel G, Wagner H. Qualitative und quantitative Analyse von Herzglykosiddrogen durch HPLC-Verfahren. Planta Med. 1980; 39(6): 125-134.
[23] Kopp B, Jurenitsch J, Czernia B, Kubelka W. Separation of cardiac glycosides of Urginea maritima by high-performance liquid chromatography; improvement by serial coupling of several polar reversed phase columns. J Chromatogr. 1983; 257: 137-139.
[24] Verbiscar AJ, Patel J, Banigan TF, Schatz RA. Scilliroside and other scilla compounds in red squill. J Agric Food Chem. 1986; 34(6): 973-979.
[25] Knittel DN, Stintzing FC, Kammerer DR. Simultaneous determination of bufadienolides and phenolic compounds in sea squill (Drimia maritima (L.) Stearn) by HPLC-DAD-MSn as a means to differentiate individual plant parts and developmental stages. Anal Bioanal Chem. 2014; 406(24): 6035-6050.
[26] The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit. ICH Q2B: Validation of analytical procedures. London: The European agency for the evaluation of medicinal products. Human medicines evaluation unit, 1996.
[27] Shekarchi M, Hajimehdipoor H, Khanavi M, Adib N, Bozorgi M, Akbariadergani B. A validated method for analysis of Swerchirin in Swertia longifolia by high performance liquid chromatography. Phcog Mag. 2010; 6(21): 13-18.
[28] Hajimehdipoor H, Mokhtarikondori B, Amin Gh, Adib N, Rastegar H, Shekarchi M. Development of a valdated HPLC method for the simultaneous determination of flavonoids in Cuscuta chinensis Lam. By ultra-violet detection. Daru. 2012; 20(1): 57.
[29] Shekarchi M, Ramezany F, Shams Ardekani MR, Lamshöft M, Rastegar H, Eftekhari M, Khanavi M. An improved HPLC method for determination of colocynthin in colocynth, Res J Pharmacogn. 2015; 2(4): 39-48.